Magellan Stem Cells was delighted to take part in the AusBiotech International Conference 2025 in Melbourne where we showcased Magellan’s cell-manufacturing capabilities. Across the four days of the conference, Magellan representatives engaged with hundreds of attendees and participants. As one of the few Therapeutic Goods Administration-licenced GMP-certified CDMOs for cell therapies in Australia, Magellan has […]
Magellan is pleased to announce the results of our Phase 1/2 allogeneic (donor) stem cell trial. The findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI)
Australia’s Federal Health Minister announces $7 million grant to Magellan Stem Cells
NOTE: Magellan Stem Cells does not treat patients. For those seeking more information on osteoarthritis treatment, please contact our collaborative clinical research partner, Melbourne Stem Cell Centre Research
For more information please email info@magellanstemcells.com.au or call 03 9270 8080
